Advent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...

Post the completion of this acquisition, Advent intends to explore the merger of its portfolio company, Cohance Lifesciences with Suven, to...

Market capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...

Announcement expected as early as Monday morning. Open offer if fully subscribed to could make it a $1 bn deal

Promoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...

Buyout firms Advent International, Baring Private Equity Asia (now owned by EQT), Bain Capital, Blackstone, Carlyle and KKR are among those...

The US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to become one ...

The transaction is Advent’s fifth investment in India over the past 12 months

Three private equity– led investment platforms have been created specifically targeting the API space, while at least half a dozen transact...

Hyderabad-based Cronus is engaged in development, manufacturing and sale of veterinary pharmaceutical products and has a large exposure in ...

ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two pe...

The company has seen a near five-fold jump in its share price, giving promoters Kumar and his partner KR Ravishankar an additional reason t...

Through Viyash, Carlyle plans to deploy about $300 million in India, sources said. Set up in 2019, Hyderabad-based Viyash is engaged in man...

Spark Capital is advising the PE fund for the stake sale. The proposed deal is expected to value Corona at Rs.2000-2400 crore.

Launched by ex-Biocon executive Ajay Bharadwaj, the Rs 1,200 crore Anthem Biosciences competes with Syngene International and GVK Bio. O3 C...

The US private equity fund is understood to have pipped a rival offer from a consortium consisting another PE fund Carlyle Group and former...

Advent will compete with Carlyle that has teamed up with former Mylan Labs CEO Hari Babu, said multiple sources with knowledge of the matte...